BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $535 from $518 and keeps a Buy rating on the shares. The firm cites the company’s Q3 earnings and revenue beat, with procedure volume growth of 18% also topping consensus by 100bps, the analyst tells investors in a research note. With a growing slate of regulatory approvals for Dv5, the pace of Dv5 growth should continue even into the broader launch in the second half of FY25, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $565 from $503 at Baird
- Intuitive Surgical price target raised to $538 from $495 at Piper Sandler
- Closing Bell Movers: Netflix gains 5% as Q3 earnings, Q4 guidance top estimates
- ISRG Earnings: Intuitive Surgical’s Financial Results Beat Estimates
- Intuitive Surgical raises FY24 procedure growth view to 16%-17% from 15.5%-17%